about
Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic HyperplasiaDoes Inflammation Mediate the Obesity and BPH Relationship? An Epidemiologic Analysis of Body Composition and Inflammatory Markers in Blood, Urine, and Prostate Tissue, and the Relationship with Prostate Enlargement and Lower Urinary Tract Symptoms.Adiponectin deficiency contributes to the development and progression of benign prostatic hyperplasia in obesity.Pathway-based expression profiling of benign prostatic hyperplasia and prostate cancer delineates an immunophilin molecule associated with cancer progression.Survivin and NAIP in Human Benign Prostatic Hyperplasia: Protective Role of the Association of Serenoa repens, Lycopene and Selenium from the Randomized Clinical Study.
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Endocrine control of benign prostatic hyperplasia.
@en
type
label
Endocrine control of benign prostatic hyperplasia.
@en
prefLabel
Endocrine control of benign prostatic hyperplasia.
@en
P2093
P2860
P356
P1433
P1476
Endocrine control of benign prostatic hyperplasia
@en
P2093
A E Calogero
R A Condorelli
P2860
P304
P356
10.1111/ANDR.12186
P577
2016-04-18T00:00:00Z